Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 35,000 LXEO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 35,000 | n/a |
| Jun 5, 2026 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 6,408 | n/a |
| Nov 6, 2025 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 10,632 | n/a |
| Jun 30, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 22,916 | n/a |
| Jul 8, 2024 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 36,000 | n/a |
| Jun 13, 2024 | iTeos Therapeutics, Inc. (ITOS) | Grant/Award | 24,200 | n/a |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 48,628 | n/a |